NCDB Analysis of Melanoma 2004-2015: Epidemiology and Outcomes by Subtype, Sociodemographic Factors Impacting Clinical Presentation, and Real-World Survival Benefit of Immunotherapy Approval.

Cancers (Basel) · 2021 · PMC8004999 · PMID 33810182

Europe PMC DOI

hedged sentence

0.0730

closest p · 1.5× alpha

0.0730

boldest claim

The sentences

did not reach statistical significancep -value = 0.073so close (0.05 < p ≤ 0.1)

We noted a 20% improvement in survival for Caucasians with the introduction of immunotherapy (adjusted HR 0.80, 95% CI 0.77–0.83, p < 0.001); however, the difference did not reach statistical significance for African American patients (adjusted HR 0.80, 95% CI 0.62–1.02, p -value = 0.073). 4.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.